Physician profile
John C Markovich
NPI 1821262056
$1,439.56
in general payments reported to CMS, 2019-2025
19 companies · $307 in 2025
The $307 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $112 · 2022: $226 · 2023: $298 · 2024: $277 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $286.42 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Corium, LLC | $242.27 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $182.64 | 2019-2024 | |
| Cranial Technologies, INC | $142.08 | 2019-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $79.46 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $69.86 | 2022-2025 | Bexsero, Penmenvy |
| Kaleo, INC. | $67.49 | 2019-2022 | |
| Neos Therapeutics, LP | $60.67 | 2023-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Sanofi-Aventis U.S. LLC | $52.96 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.91 | 2020-2023 | Gattex |
| Alk-Abello, INC | $41.15 | 2023-2025 | Neffy, Grastek, Odactra |
| Tris Pharma INC | $37.70 | 2019-2024 | |
| Quidel Corporation | $29.44 | 2019 | |
| Abbott Laboratories | $20.59 | 2020 | |
| Genentech USA, INC. | $18.40 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $15.91 | 2024 | |
| Shire North American Group INC | $15.29 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.25 | 2025 | Qelbree |
| Sanofi Pasteur INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Markovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.